Outcomes
What were the main findings from the study?
- MICARDISPLUS® lowered both SBP and DBP to a significantly greater degree than valsartan/HCTZ in the last 6 hours of the dosing interval (p<0.0001 for SBP and p<0.0007 for DBP.5
- Greater blood pressure reductions over 24-hours were also achieved with MICARDISPLUS® compared with valsartan/HCTZ.5
- MICARDISPLUS® provides protection against the early morning blood pressure surge in overweight/obese patients with diabetes and hypertension.5
/Graph62.jpg "title text")
Calendar
Tools and Downloads
- Clinical Abstract Library
- Expert Interview Library
- ONTARGET® Results Webcast
- Free ONTARGET® Online Publication Download
- Cardiovascular Risk Guidelines
- Renin Angiotensin System in Cardiovascular Medicine Journal
My Alerts
You will shortly be able to create your own personal alerts service bringing the latest MICARDIS® news and updates direct to your inbox. Watch this space for more information.
